Sjogren syndrome

Current Opinion in Ophthalmology

Volumn 11, Issue 6, 2000, Pages 449-454

  Tabbara, K F ^a   Vera Cristo, C L ^a  

^a NONE   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; HUMAN; KERATOCONJUNCTIVITIS SICCA; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; TISSUE INJURY; TREATMENT INDICATION; XEROSTOMIA; AUTOIMMUNITY; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; LACRIMAL APPARATUS; PATHOLOGY; PROGNOSIS; REVIEW; SECRETION; TRANSPLANTATION;

EYE DROPS; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOCONJUNCTIVITIS SICCA; LACRIMAL APPARATUS; OPHTHALMIC SOLUTIONS; PROGNOSIS; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 0033625958     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200012000-00011     Document Type: Article

References (32)

1. Sjogren's syndrome
2. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome
3. Are endogenous retroviruses involved in human autoimmune disease?
4. Sjogren's syndrome
5. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice
6. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-Ipr/Ipr mice
7. Association of Epstein-Barr virus (EBV) with Sjogren's syndrome: Differential EBV expression between epithelial cells and lymphocytes in salivary glands
8. Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjogren's syndrome patients
9. Detection of Epstein-Barr genomes in normal human lacrimal glands
10. Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type 1-associated and idiopathic Sjogren's syndrome
11. Relationship between Sjogren's syndrome and human T-lymphotropic virus type-1 infection: Follow-up study of 83 patients
12. Human T-cell lymphotropic virus type 1-associated myelopathy, Sjogren's syndrome, and lymphocytic pneumonitis
13. Immunohistological analysis of tumor growth factor β1 expression in normal and inflamed salivary glands
14. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome
15. Class II MHC antigen expression on epithelial cells of salivary glands from patients with Sjogren's syndrome
16. Regulation of human leukocyte antigen expression in human conjunctival epithelium
17. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome
18. Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1 and TNF receptor-induced cell death
19. Granzyme and perforin A expressed in lacrimal glands of patients with Sjogren's syndrome
20. Sjogren's syndrome: Pathogenesis
21. Ophthalmological aspects in allogenic bone marrow transplantation: Sjogren-like syndrome in graft-versus-host disease
22. Diagnosis and management of dry eye syndrome
23. New strategies in the treatment of dry-eye states (Castroviejo Lecture)
24. Dry eye
25. Use of topical cyclosporine A in primary Sjogren's syndrome
26. Treatment with anti-CD86 costimulatory molecule prevents autoimmune lesions in murine Sjogren's syndrome through upregulated Th2 response
27. Etanercept therapy in rheumatoid arthritis. A randomized, control trial
28. D penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjogren's syndrome
29. Regulation of mucin secretion by P2Y2 receptors in conjunctival cells
30. Corneal surface regularity and the effect of artificial tears in aqueous tears deficiencies
31. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome
32. Treatment of dry eye by autonomous serum application in Sjogren's syndrome